[Effect of streptokinase, traskolan and sefril on the development of experimental osteomyelitis. I. Evaluation of local bone changes].
D000818:Animals; D000891:Anti-Infective Agents, Local / Q000008:administration & dosage*; D007611:Aprotinin / Q000008:administration & dosage*; D002511:Cephalosporins / Q000008:administration & dosage*; D002515:Cephradine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005260:Female; D005269:Femur; D007263:Infusions, Parenteral; D008297:Male; D010019:Osteomyelitis / Q000188:drug therapy*; D011817:Rabbits; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013300:Streptokinase / Q000008:administration & dosage*
D000891:Anti-Infective Agents, Local; D002511:Cephalosporins; D007611:Aprotinin; D013300:Streptokinase; D002515:Cephradine
Wpływ streptazy, traskolanu i sefrilu na rozwój doświadczalnego zapalenia kości. I. Ocena zmian miejscowych w kości.